VXL Instruments FY26 loss narrows to ₹48.29 lakh post-CIRP resolution
- Net loss narrowed to ₹48.29 lakh in FY26 from ₹652.51 lakh in FY25
- Revenue from operations collapsed to ₹7.55 lakh, down 88.6% YoY
- Exceptional items reduced to ₹21.75 lakh from ₹554.69 lakh in prior year
- 40th AGM scheduled for October 26, 2026, to adopt FY26 results

*this image is generated using AI for illustrative purposes only.
VXL Instruments Limited reported a net loss of ₹48.29 lakh for the fiscal year ended March 31, 2026, a substantial improvement from the ₹652.51 lakh loss recorded in FY25. The company will convene its 40th Annual General Meeting on October 26, 2026, to adopt these audited financial statements.
This convening marks a step toward normalizing statutory compliances after the Corporate Insolvency Resolution Process (CIRP). The reduction in losses was driven by the absence of the massive bad debt write-offs that characterized the previous year, despite revenue collapsing further to ₹7.55 lakh due to continued operational suspension.
Financial Performance Context
The company’s financial position in FY26 reflected severe operational disruption due to the insolvency proceedings initiated in November 2024. Revenue from operations fell 88.6% YoY to ₹7.55 lakh, consisting entirely of scrap sales, while total income dropped to ₹23.79 lakh from ₹82.04 lakh in the previous year. Employee benefit expenses were nil as the workforce exited during the process.
| Metric | FY26 (₹ lakh) | FY25 (₹ lakh) | Change |
|---|---|---|---|
| Revenue from Operations | 7.55 | 66.37 | -88.6% |
| Other Income | 16.24 | 15.67 | +3.6% |
| Total Income | 23.79 | 82.04 | -71.0% |
| Net Loss After Tax | (48.29) | (652.51) | N/A |
What the Numbers Show
The narrowing of net loss from ₹652.51 lakh in FY25 to ₹48.29 lakh in FY26 is primarily attributable to the non-recurrence of exceptional items. In FY25, the company booked an exceptional item of ₹554.69 lakh related to bad debt write-offs. In FY26, exceptional items were limited to a net charge of ₹21.75 lakh, comprising write-offs of Property, Plant and Equipment and cash balances. Excluding these non-recurring charges, the underlying operating loss remained significant, with Profit before Tax (before exceptional items) standing at (₹26.55) lakh in FY26 compared to (₹97.82) lakh in FY25, indicating a continued lack of core business activity.
Resolution Plan Implementation
The NCLT Mumbai Bench approved the resolution plan submitted by NG Organics Private Limited and Nitinbhai Govindbhai Patel on September 9, 2026. Consequently, the CIRP has concluded, and the company has entered the implementation stage under the supervision of a Monitoring Committee chaired by Jayanti Lal Jain. The committee is tasked with completing pending statutory compliances, including the overdue AGMs for FY25 and FY26.
Meeting Logistics and Voting
The 40th AGM will be held virtually at 4:00 pm IST. Physical attendance and proxy appointments are dispensed with in compliance with MCA and SEBI circulars. Shareholders can cast votes through remote e-voting during the window from October 22 to October 25, 2026.
| Activity | Date and Time |
|---|---|
| E-voting Start | October 22, 2026, at 9:00 am |
| E-voting End | October 25, 2026, at 5:00 pm |
| Cut-off Date | October 19, 2026 |
| AGM Date | October 26, 2026, at 4:00 pm |
The e-voting facility is provided by Bigshare Services India Private Limited. M/s Nishtha Khandelwal and Associates have been appointed as the scrutinizer for the voting process.
Historical Stock Returns for VXL Instruments
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.43% | -1.97% | +80.26% | +66.06% | +66.06% | -16.97% |
What specific operational revival strategies will NG Organics Private Limited implement to restart core manufacturing activities after the resolution plan's implementation?
How might the successful conclusion of VXL Instruments' CIRP influence the valuation and acquisition appetite for other distressed micro-cap industrial companies in India?
Will the Monitoring Committee's oversight lead to immediate capital infusion or debt restructuring to address the company's continued negative operating cash flows?


































